Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands

The Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA) demonstrated the efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) in preventing vaccine-type community-acquired pneumonia and vaccine-type invasive pneumococcal disease in elderly subjects. We examined the cost-effect...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Respir J
Main Authors: Mangen, Marie-Josée J., Rozenbaum, Mark H., Huijts, Susanne M., van Werkhoven, Cornelis H., Postma, Douwe F., Atwood, Mark, van Deursen, Anna M.M., van der Ende, Arie, Grobbee, Diederick E., Sanders, Elisabeth A.M., Sato, Reiko, Verheij, Theo J.M., Vissink, Conrad E., Bonten, Marc J.M., de Wit, G. Ardine
Formato: Artigo
Idioma:Inglês
Publicado em: European Respiratory Society 2015
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4750466/
https://ncbi.nlm.nih.gov/pubmed/26160871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.00325-2015
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados